Effects of alpha- and beta-receptor blocking agents on catecholamine and 5-hydroxytryptamine induced peroxidase and amylase secretion from guinea pig submandibular gland.
D000681:Amylases / Q000378:metabolism*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D004298:Dopamine / Q000008:administration & dosage; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D008722:Methods; D009638:Norepinephrine / Q000494:pharmacology; D010544:Peroxidases / Q000378:metabolism*; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical; D013363:Submandibular Gland / Q000201:enzymology*; D013806:Theophylline / Q000494:pharmacology
D002395:Catecholamines; D018492:Dopamine Antagonists; D012702:Serotonin Antagonists; D010643:Phenoxybenzamine; D003994:Bucladesine; D011433:Propranolol; D013806:Theophylline; D010544:Peroxidases; D000681:Amylases; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine